Nine Chapters Capital Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-3,200
Closed -$401K 180
2016
Q3
$401K Buy
+3,200
New +$413K 2.83% 7
2015
Q4
Sell
-25,300
Closed -$3.54M 174
2015
Q3
$3.54M Buy
25,300
+1,100
+5% +$165K 0.31% 69
2015
Q2
$3.97M Buy
+24,200
New +$3.87M 0.33% 56
2015
Q1
Sell
-26,000
Closed -$3.27M 1005
2014
Q4
$3.27M Buy
+26,000
New +$3.21M 0.28% 82
2014
Q3
Sell
-27,600
Closed -$2.97M 1035
2014
Q2
$2.97M Buy
27,600
+18,900
+217% +$1.95M 0.24% 107
2014
Q1
$866K Buy
+8,700
New +$787K 0.1% 300
2013
Q4
Sell
-27,400
Closed -$2.29M 826
2013
Q3
$2.29M Buy
+27,400
New +$2.35M 0.27% 102

Other funds holding ELV

Nine Chapters Capital Management's ELV Position: Q4 2016 in Review

Nine Chapters Capital Management sold out of Elevance Health (ELV) in Q4 2016, closing a stake of 3,200 shares — an estimated $401K sold.

Nine Chapters Capital Management first reported a position in ELV in Q3 2013 and held it in 7 quarters. The position peaked at $3.97M in Q2 2015. 784 funds tracked by Wall St. Rank hold ELV as of Q4 2016.

  • Nine Chapters Capital Management reported no remaining Elevance Health position as of Q4 2016 after selling out during the quarter.
  • Nine Chapters Capital Management sold 3,200 Elevance Health shares in Q4 2016, an estimated $401K.
  • Nine Chapters Capital Management first reported a position in Elevance Health in Q3 2013 and held it in 7 quarters.
  • Nine Chapters Capital Management's Elevance Health position peaked at $3.97M in Q2 2015.
  • 784 funds tracked by Wall St. Rank held Elevance Health as of Q4 2016.

Based on Nine Chapters Capital Management's 13F filing for Q4 2016, filed 10 Feb 2017.